Mortality Of Malignant Melanoma In Central Serbia, In The Period 1999-2015
Keywords:
malinant melanoma, mortality, risk factors, SerbiaAbstract
Introduction: Malignant melanoma is one of the rarest but the most deadly form of skin cancer.
Objective: The objective of this paper was to analyze the epidemiological characteristics and trends of mortality from malignant melanoma of the population of Central Serbia in the period 1999-2015.
Methods: The study was designed as a retrospective descriptive epidemiological study. Standardized mortality rates were used in statistical data processing. A linear trend model and regression analysis were used to examine trends in malignant melanoma mortality.
Results: In Serbia, malignant melanoma mortality shows an increasing trend. The overall age-adjusted melanoma death rate was 2.6 per 100 000 with a higher death rate among men (3.03per 100 000) than among women (2.1 per 100 000). Malignant melanoma mortality rates increase with age in both sexes and are highest in the age group of 75 and older. The highest increase in mortality in men is recorded in the age group of 65-69 years, with an average percentage increase of 21.33 (95% CI, 8.40 - 51.05), while in women the largest increase in mortality was recorded in the age group 35-39 years, with an average percentage increase of 31.4 and in the age group of 70-74 years, 12.9 .
Conclusions: The trend of increasing mortality from malignant melanoma in Serbia is similar to those in most developed countries. Education and improvement of the awareness of the general population and among health professionals remain vital to reducing melanoma mortality in the future.
References
GLOBOCAN 2020. Cancer Incidence and Mortality Worldwide. Accessed March 19, 2020. Available from: http:// https://gco.iarc.fr/
Gutiérrez-González E, López-Abente G, Aragonés N, et al. Trends in mortality from cutaneous malignant melanoma in Spain (1982-2016): sex-specific age-cohort-period effects. J Eur Acad Dermatol Venereol. 2019;33(8):1522‐1528. DOI: 10.1111/jdv.15565
McKenna MR, Stobaugh DJ, Deepak P. Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System. J Gastrointestin Liver Dis. 2014;23:267-271. DOI: 10.15403/jgld.2014.1121.233.mrmk
Nikolaou V, Stratigos AJ. Emerging trends in the epidemiology of melanoma. Br J Dermatol. 2014;170(1):11–19. DOI: 10.1111/bjd.12492 PMID: 23815297
Guy GP Jr, Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC. Vital signs: Melanoma incidence and mortality trends and projections – United States, 1982–2030. MMWR Morb Mortal Wkly Rep. 2015;64(21):591–6.) PMID: 26042651
Kaminska-Winciorek G, Wydmanski J, Gajda M, Tukiendorf A. Melanoma awareness and prevalence of dermoscopic examination among internet users: a cross-sectional survey. Postepy Dermatol Alergol. 2016;33(6):421-428. DOI:10.5114/pdia.2016.63297
GLOBOCAN 2020. Cancer Incidence and Mortality Worldwide. Accessed March 19, 2020. Available from: http:// https://gco.iarc.fr/
Boyers LN, Karimkhani C, Naghavi M, et al. Global mortality from conditions with skin manifestations. J Am Acad Dermatol. 2014; 2. pii: S0190-9622(14)01869-6. DOI: https://doi.org/10.1016/j.jaad.2014.08.022
Lin L, Yan L, Liu Y, Yuan F, Li H, Ni J. Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study. J Hematol Oncol. 2019;12(1):96. DOI: 10.1186/s13045-019-0783-9
Sneyd MJ, Cox B. A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the world. BMC Cancer. 2013;13:372. DOI: 10.1186/1471-2407-13-372
Ghazawi FM, Le M, Lagacé F, et al. Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada. J Cutan Med Surg. 2019;23(4):394‐412. DOI: 10.1177/1203475419852048 PMID: 31132871
Jemal A, Saraiya M, Patel P, Cherala SS, Barnholtz-Sloan J, Kim J, et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol. 2011; 65: e17. DOI: 10.1016/j.jaad.2011.04.032 PMID: 22018063
Iannacone MR, Youlden DR, Baade PD, Aitken JF, Green AC. Melanoma incidence trends and survival in adolescents and young adults in Queensland, Australia. Int J Cancer. 2015;136(3):603‐609. DOI: 10.1002/ijc.28956 PMID: 24806428
Puig-Butille JA, Escámez MJ, Garcia-Garcia F, et al. Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer. Oncotarget. 2014;5(6):1439-1451. DOI:10.18632/oncotarget.1444
Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41(14):2040-2059. DOI: 10.1016/j.ejca.2005.03.034 PMID: 16125929
Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Adv Exp Med Biol 2008;624:89-103. DOI: 10.1007/978-0-387-77574-6_8 PMID: 18348450
Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol. 2014;810:120‐140. DOI: 10.1007/978-1-4939-0437-2_7 PMID: 25207363
International Agency for Research on Cancer. Cancer Mortality Database. Accessed March 9, 220. Available from: https://www-dep.iarc.fr/WHOdb/WHOdb.htm
Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: Projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Investig Dermatol. 2016;136(6):1161–71. DOI:10.1016/j.jid.2016.01.035 PMID: 26902923
Watson M, Geller AC, Tucker MA, Guy GP Jr, Weinstock MA. Melanoma burden and recent trends among non-Hispanic whites aged 15–49 years, United States. Prev Med. 2016;91:294–8. DOI: 10.1016/j.ypmed.2016.08.032 PMID: 27565055
Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009;27(1):3–9. DOI: 10.1016/j.clindermatol.2008.09.001 PMID: 19095149
Aitken JF, Youlden DR, Baade PD, Soyer HP, Green AC, Smithers BM. Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014. Int J Cancer. 2018;142(8):1528‐1535. DOI: 10.1002/ijc.31141 PMID: 29105744
Khosrotehrani K, Dasgupta P, Byrom L, Youlden DR, Baade PD, Green AC. Melanoma survival is superior in females across all tumour stages but is influenced by age. Arch Dermatol Res. 2015;307(8):731–40. DOI: 10.1007/s40487-020-00109-1 PMID: 32700073
Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356‐387. DOI: 10.1016/j.ejca.2018.07.005 PMID: 30100160
Weir HK, Marrett LD, Cokkinides V, Barnholtz-Sloan J, Patel P, Tai E, et al. Melanoma in adolescents and young adults (ages 15–39 years): United States, 1999–2006. J Am Acad Dermatol. 2011;65(5) Suppl 1:S38–49. DOI: 10.1016/j.jaad.2011.04.038 PMID: 22018066
Li WQ, Cho E, Weinstock MA, Mashfiq H, Qureshi AA. Epidemiological assessments of skin outcomes in the nurses’ health studies. Am J Public Health. 2016;106(9):1677–83. DOI: 10.2105/AJPH.2016.303315 PMID: 27459457
Erdei E, Torres SM. A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther. 2010;10(11):1811‐1823. DOI: 10.1586/era.10.170 PMID: 21080806
Schmidt A, Nanney LB, Boyd AS, King LE, Ellis DL. Oestrogen receptor-β expression in melanocytic lesions. Exp Dermatol. 2006;15:971–980. DOI: 10.1111/j.1600-0625.2006.00502.x PMID: 17083364
Koomen ER, Joosse A, Herings, et al. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study. Ann Oncol. 2009;20(2):358–364. DOI: 10.1093/annonc/mdn589 PMID: 18725391
Karimkhani C, Green AC, Nijsten T, et al. The global burden of melanoma: results from the Global Burden of Disease Study 2015. Br J Dermatol. 2017;177(1):134‐140. DOI: 10.1111/bjd.15510 PMID: 28369739
Lasithiotakis KG, Petrakis IE, Garbe C. Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment. Melanoma Res. 2010;20(3):163-70. DOI: 10.1097/CMR.0b013e328335a8dd PMID: 20375923
National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Melanoma of the Skin. Available from: https://seer.cancer.gov/statfacts/html/melan.html.
Veierod MB, Adami HO, Lund E, Armstrong BK, Weiderpass E. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev. 2010;19(1):111-120. DOI: 10.1158/1055-9965.EPI-09-0567 PMID: 20056629
Armstrong BK. How sun exposure causes skin cancer: An epidemiological perspective In: Hill D, Elwood JM, English D. Prevention of Skin Cancer. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2004: 89-116.
Kricker A, Armstrong BK, Goumas C, et al. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007;18(3):295-304. DOI: 10.1007/s10552-006-0091-x PMID: 17206532
Pfahlberg A, Kölmel KF, Gefeller O; Febim Study Group. Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation- induced melanoma. Br J Dermatol. 2001;144(3):471‐475. DOI: 10.1046/j.1365-2133.2001.04070.x PMID: 11260001
Published
Issue
Section
License
Copyright (c) 2022 Milica Pantovic, Ognjen Djordjevic, Svetlana Radevic, Dragic Bankovic, Katarina Parezanovic Ilic, Snezana Radovanovic
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
